Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr Kelly presentation at the breast cancer conference gives a good run down on Leronlimab treating cancer.
https://d1io3yog0oux5.cloudfront.net/cytodyn/files/video/TNBC.mp4
One NewsPH affiliate is Bloomberg News so the ones that will be tuning in most likely will be investors.
Completely agree with this and really looking forward to the segment Sunday. I'll say the fact that it's an hour long has peaked my curiosity. That's an extreme amount of time for an interview. It also goes to show the depth of Leronlimab, having enough subject matter to fill an hour long show.
One million vials of Leronlimab.. $1,200,000,000 revenue. That's only inventory on hand, Samsung can produce at least one million per month. CytoDyn is positioned for immediate revenue on a large scale with EUA. It all starts in the Philippines.
I think we're back over $3 with the interview on Saturday. Confirmed order from the Philippines puts CYDY over $5 headed towards $7
You could possibly contact Dr Jay L., the trial location is at his facility in San Francisco.
"Quest Clinical Research | San Francisco" https://www.questclinical.com
LOL! 35% from it's bottom! It's not even back to pre split levels. This stock has one more play, dump the news when they claim applied for EUA that's the best it will do because it will tank when the FDA sends it back for another trial.
Oh ok, the shorts...so why isn't ANYONE buying it??!!!! It should be squeezing right now..it's not because... NOBODY is buying it. Nobody is buying it because the market doesn't see it as a good investment.
I wouldn't be so excited about 5% that stock should be at $30 at least right now. What's wrong with it? Why isn't anyone buying it?
HGEN is garbage, day traders pushed it up to $19 it tested it three times, couldn't break through so they dumped. Nobody want that stock.. because nobody wants lenz.. NOBODY. it's sad when it could've even break past $20
Leronlimab.... Leronlimab.... Leronlimab.....a small debt with fife is meaningless .. because... Leronlimab. If you don't own shares because of Leronlimab you don't have what it takes for investing.
I agree with you on this one. I agree when you say that the Philippines definitely want Leronlimab. And I agree that the Philippines won't GIVE money to CytoDyn, the Philippines will purchase Leronlimab from CytoDyn to the tune if $100 million
Thanks for the link. What a wonderful story of survival. Leronlimab saved another life and this is the reason I'm invested in CytoDyn. I'm amazed at the amount of testimonials from both doctors and patients of miraculous survivals after receiving Leronlimab. Now not only in the U.S. but in the Philippines also.
So doctors across the Philippines are requesting Leronlimab, they are stocking Leronlimab in their hospitals, the government approved CSP for Leronlimab, the government mentioned during a session of congress they are working on approving Leronlimab, Leronlimab saved the life of their president, CytoDyn has 200,000 vials for the Philippines...and you think CytoDyn won't be selling Leronlimab?!! LOL! OKAAAY!!
Another thing we know NOBODY is asking for lenz, nobody!
So are you trying to say the UK is also stocking Leronlimab in their hospitals??!!! Or is it only the Philippines?
That's right, no PR on hospitals stocking enough Leronlimab for 100 patients. I think you are on to something, stocking enough for 100 patients would make for a major PR so it's safe to say there's even bigger news developing because surly NP would have PR'd that news. It must be they are finalizing the EUA.
CytoDyn released that data to the Philippines and they in turn approved Leronlimab for CSP and to be stocked in their hospitals across the country. Philippines will approve Leronlimab for EUA, Leronlimab will be the SOC for all covid patients, many other countries will follow shortly after.
Yep, $20 pop on approval news then it's up from there.. additional countries approval...then nasdaq...then BLA...then longhaulers....then cancer BTD...and it keeps going
I like the sound of $20 per share! That's a good prediction, should hit that any day now with approval in the Philippines.
And this is not only a video, this is an interview by a news media outlet with alot of viewers. They have 5 million followers on twitter alone.
"ABS-CBN News Channel on Twitter: "Leronlimab, drug used by ex-president Estrada, touted as #COVID19 treatment https://t.co/HXPtBDEao9" / Twitter"
Leronlimab, drug used by ex-president Estrada, touted as #COVID19 treatment https://t.co/HXPtBDEao9
— ABS-CBN News Channel (@ANCALERTS) April 30, 2021
That won't happen for about a year because lenzsalinemab isn't available there yet. Actually lenz most likely won't be available then either. It's a good thing Leronlimab is available in the hospitals now to save their life.
"Leronlimab, drug used by ex-president Estrada, touted as COVID-19 treatment | ABS-CBN News" https://news.abs-cbn.com/amp/news/04/30/21/leronlimab-drug-used-by-ex-president-estrada-touted-as-covid-19-treatment?__twitter_impression=true
CYDY has a PR coming out soon, a major PR. The government of a country doesn't allow a drug to be stocked , enough for 100 patients, in EVERY hospital without the intention of approving it. There is no way possible that the doctors with critical Covid patients in those hospitals will not be prescribing a drug that is available to them.
That was my thought after hearing a hospital can stock enough Leronlimab for 100 patients with only one CSP. The amount of paper work for one eIND here in the U.S. is enough to discourage a doctor from using it. This shows the level of confidence the Philippines FDA has with Leronlimab.
Leronlimab will achieve the endpoint of a critical patients stay in the hospital by extubating and sending them home. That's all the data Philippines will need. After they see Leronlimab empty the ICU it will be approved.
Mortality and discharge numbers could very well lead to an approval. With the FDA seeing numbers that can be confirmed coming from hospitals not just individual doctors that could lead to an EUA while actually then conducting a trial. There is no better evidence than empty ICU beds.
And while ivermectin must undergo a trial Leronlimab is being stocked in hospitals to treat patients so it's clear the Philippines WANT Leronlimab but are unsure about ivermectin. After all it is a drug for animals,... but I hear it works great on donkeys.
Yesterday it was confirmed Leronlimab is for sale in the Philippines, I believe you confirmed the price at $2740, so now today it's Duterte changed his mind and would rather kill grandma to save a Buck?
So now that you confirmed Leronlimab is indeed being sold in the Philippines and the other poster here confirmed they are paying $2475 for Leronlimab, what is your guess on the price for the 600,000 viales going to Brazil?
$2475 for Leronlimab x 200,000....WOW! CytoDyn will have
$495,000,000 revenue!!!!!!!
Here you go confirmed by justdafactss, Leronlimab is being sold in the Philippines
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163422796
WOW! GREAT NEWS!! Leronlimab is available to purchase in the Philippines!!!!!!!!!
So you're saying even with the lower dosage patients in the trial who are stage 4 chemo resistant have survived over a year? Appears Leronlimab is working incredibly well, I would say the higher dose is probably going for a cure.
Another article mentioning Leronlimab along with ivermectin in the Philippines
https://www.philstar.com/headlines/2021/04/26/2093841/philippines-sees-accelerated-vaccine-deliveries
Philippines wants trials on those drugs meanwhile they are stocking Leronlimab in hospitals for doctors to treat patients. No need to waste time on trials with Leronlimab's impressive data.
It was never answered because it doesn't pertain to Leronlimab. Leronlimab was never rejected by the FDA, Post a link from the FDA saying they rejected Leronlimab. But it's nice to see that you too agree that Leronlimab will have significant sales in Asia, Brazil, and India